Foreign-Trade Zone (FTZ) 49; Authorization of Production Activity; Merck, Sharp & Dohme LLC; (Pharmaceutical Products for Research and Development); Rahway, New Jersey

📖 Research Context From Federal Register API

Key Dates

Citation: 90 FR 10048

Public Participation

In Plain English

What is this Federal Register notice?

This is a notice published in the Federal Register by Commerce Department, Foreign-Trade Zones Board. Notices communicate information, guidance, or policy interpretations but may not create new binding obligations.

Is this rule final?

This document is classified as a notice. It may or may not create enforceable regulatory obligations depending on its specific content.

Who does this apply to?

Consult the full text of this document for specific applicability provisions. The affected parties depend on the regulatory scope defined within.

When does it take effect?

No specific effective date is indicated. Check the full text for date provisions.

Why it matters: This notice communicates agency policy or guidance regarding applicable regulations.

Document Details

Document Number	2025-02919
FR Citation	90 FR 10048
Type	Notice
Published	Feb 21, 2025
Effective Date	-
RIN	-
Docket ID	B-56-2024
Pages	10048–10048 (1 pages)
Text Fetched	Yes

Agencies & CFR References

Agency Hierarchy:

Commerce Department→Foreign-Trade Zones Board

CFR References:

None

Linked CFR Parts

Part	Name	Agency
No linked CFR parts

Paired Documents

Type	Proposed	Final	Method	Conf
No paired documents

External Links

View on FederalRegister.gov Search Regulations.gov

📋 Extracted Requirements 0 found

No extractable regulatory requirements found in this document. This is common for documents that:

Incorporate requirements by reference (IBR) to external documents
Are procedural notices without substantive obligations
Contain only preamble/explanation without regulatory text

▼ Full Document Text (158 words · ~1 min read)

Text Preserved

<NOTICE>
 
 DEPARTMENT OF COMMERCE 
 <SUBAGY>Foreign-Trade Zones Board</SUBAGY>
 <DEPDOC>[B-56-2024]</DEPDOC>
 <SUBJECT>Foreign-Trade Zone (FTZ) 49; Authorization of Production Activity; Merck, Sharp & Dohme LLC; (Pharmaceutical Products for Research and Development); Rahway, New Jersey</SUBJECT>
 On October 18, 2024, Merck, Sharp & Dohme LLC submitted a notification of proposed production activity to the FTZ Board for its facility within Subzone 49Y, in Rahway, New Jersey. 
 
 The notification was processed in accordance with the regulations of the FTZ Board (15 CFR part 400), including notice in the 
 <E T="04">Federal Register</E>
 inviting public comment (89 FR 87542-87543, November 4, 2024). On February 18, 2025, the applicant was notified of the FTZ Board's decision that no further review of the activity is warranted at this time. The production activity described in the notification was authorized, subject to the FTZ Act and the FTZ Board's regulations, including section 400.14.
 
 <SIG>
 <DATED>Dated: February 18, 2025.</DATED>
 <NAME>Elizabeth Whiteman,</NAME>
 Executive Secretary. 
 </SIG>
 
 <FRDOC>[FR Doc. 2025-02919 Filed 2-20-25; 8:45 am]</FRDOC>
 </NOTICE>
						

This text is preserved for citation and comparison. View the official version for the authoritative text.

📄 PDF 🏛️ Official Version